Blazing a trail with fast tech efficiencies
We are working with novel clinical trials which span several years, and we need to operate at the leading edge of technological capabilities. Blazor is that: a global software shift that’s just the beginning for emerging health tech efficiencies.
Navigating the future of clinical trial innovation
I can boldly say that Spiral is a global leader in novel clinical trial innovation and, more specifically, in randomisation. We’re redefining the parameters of randomisation in all its forms and building a future-ready platform with Blazor’s next-gen development framework - Audrey.
Turning conversations into clinical innovation
This circuit presents a critical opportunity for collaboration with researchers leading and advancing infectious disease research. A primary message for us all; ‘Engage Early.’
Insights and inspiration: the 2024 ASID Clinical Research Network Meeting
Spiral spent an inspirational and thought-provoking weekend at the 2024 ASID Clinical Research Meeting on the Gold Coast. Read the latest insights and takeaways from our founder and CEO, Audrey Shearer.
PANORAMIC honoured with prestigious award
Spiral is proud to have played a crucial role in the success of the PANORAMIC clinical trial, which, along with the PRINCIPLE trial, has recently been awarded the prestigious Prix Galien Best Public Sector Innovation Award 2024.
Compliance: How does this impact human-centred trials?
Spiral is navigating the intersection of big data and AI —leading the way in ethical clinical trial design. In the rapidly evolving healthcare landscape, we prioritise ethical governance, where data, compliance, and human-centred trials converge.
Navigating Change: A Comprehensive Rebuild for Our Future-Ready Software
In the fast-paced world of software, adaptability is key. Our Spinnaker software is always evolving to stay innovative. Because of this, we're now rebuilding a project from the ground up, seizing the chance to harness Blazor, a cutting-edge web development framework, as we navigate changes in the Core Protocol.
Perspective Changed, Problem Solved - Meet Cain Harland
Cain Harland, one of the minds behind Spiral's Spinnaker software, is not your typical Developer. His unique journey blends his passion for problem-solving with a commitment to advancing medical knowledge and improving patient outcomes.
Insights and Highlights: ACTA 2023
After an invigorating week at the ACTA International Clinical Trials Symposium in Melbourne, it's time to pause and reflect on an event that truly exemplified the theme ‘Changing the landscape of clinical trials.’
Mega-ROX Trial - Leveraging Spiral Software for Robust Data Management and Global Collaboration
Diane Mackle, an experienced ICU nurse and now Project Manager of the trial, plays a pivotal role here in New Zealand managing the Mega-ROX trial and its coordination with the Spiral team and Spinnaker software.
THE LONG AWAITED TAME TRIAL RESULTS ARE IN!
The TAME trial, a phase III clinical trial, aimed to investigate whether targeted therapeutic mild hypercapnia (TTMH) could improve neurological outcomes at 6 months for resuscitated cardiac arrest patients in comparison to standard care (targeted normocapnia). This study holds significant importance in exploring potential advancements in post-cardiac arrest treatment strategies.